nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B7—Epirubicin—sarcoma	0.112	0.194	CbGbCtD
Valproic Acid—CYP2B6—Thiotepa—sarcoma	0.108	0.187	CbGbCtD
Valproic Acid—SLC22A5—Dactinomycin—sarcoma	0.105	0.181	CbGbCtD
Valproic Acid—PTGS1—Etoposide—sarcoma	0.0385	0.0664	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—sarcoma	0.0351	0.0606	CbGbCtD
Valproic Acid—CYP3A4—Thiotepa—sarcoma	0.0332	0.0573	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—sarcoma	0.0252	0.0435	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—sarcoma	0.0231	0.0399	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—sarcoma	0.0222	0.0383	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—sarcoma	0.02	0.0345	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—sarcoma	0.0172	0.0297	CbGbCtD
Valproic Acid—CYP3A4—Mitoxantrone—sarcoma	0.0143	0.0246	CbGbCtD
Valproic Acid—CYP3A4—Vincristine—sarcoma	0.00982	0.017	CbGbCtD
Valproic Acid—CYP3A4—Etoposide—sarcoma	0.009	0.0155	CbGbCtD
Valproic Acid—CYP3A4—Doxorubicin—sarcoma	0.00614	0.0106	CbGbCtD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—sarcoma	0.00402	0.723	CbGdCrCtD
Valproic Acid—OGDH—mammary gland—sarcoma	0.00395	0.0344	CbGeAlD
Valproic Acid—UGT2B15—mammary gland—sarcoma	0.00356	0.031	CbGeAlD
Valproic Acid—ACADSB—mammary gland—sarcoma	0.00314	0.0273	CbGeAlD
Valproic Acid—OGDH—hematopoietic system—sarcoma	0.00241	0.0209	CbGeAlD
Valproic Acid—ABAT—mammary gland—sarcoma	0.00237	0.0206	CbGeAlD
Valproic Acid—OGDH—connective tissue—sarcoma	0.00232	0.0202	CbGeAlD
Valproic Acid—ACADSB—myometrium—sarcoma	0.00223	0.0194	CbGeAlD
Valproic Acid—HDAC9—hematopoietic system—sarcoma	0.00212	0.0185	CbGeAlD
Valproic Acid—ACADSB—seminal vesicle—sarcoma	0.00201	0.0175	CbGeAlD
Valproic Acid—UGT1A4—hematopoietic system—sarcoma	0.00196	0.0171	CbGeAlD
Valproic Acid—OGDH—cardiac atrium—sarcoma	0.00183	0.0159	CbGeAlD
Valproic Acid—OGDH—uterus—sarcoma	0.00182	0.0158	CbGeAlD
Valproic Acid—HDAC2—mammary gland—sarcoma	0.00178	0.0155	CbGeAlD
Valproic Acid—UGT1A10—liver—sarcoma	0.0017	0.0148	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—sarcoma	0.0017	0.0147	CbGeAlD
Valproic Acid—ALDH5A1—hematopoietic system—sarcoma	0.00168	0.0146	CbGeAlD
Valproic Acid—UGT1A6—testis—sarcoma	0.00167	0.0145	CbGeAlD
Valproic Acid—HDAC9—uterus—sarcoma	0.0016	0.0139	CbGeAlD
Valproic Acid—OGDH—tendon—sarcoma	0.00159	0.0139	CbGeAlD
Valproic Acid—UGT1A6—liver—sarcoma	0.00158	0.0137	CbGeAlD
Valproic Acid—OGDH—bone marrow—sarcoma	0.00154	0.0134	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—sarcoma	0.00154	0.277	CbGdCrCtD
Valproic Acid—HDAC9—lymphoid tissue—sarcoma	0.00149	0.013	CbGeAlD
Valproic Acid—ACADSB—cardiac atrium—sarcoma	0.00145	0.0126	CbGeAlD
Valproic Acid—ACADSB—uterus—sarcoma	0.00145	0.0126	CbGeAlD
Valproic Acid—HDAC9—tendon—sarcoma	0.00141	0.0122	CbGeAlD
Valproic Acid—HDAC9—bone marrow—sarcoma	0.00136	0.0118	CbGeAlD
Valproic Acid—UGT1A8—liver—sarcoma	0.00134	0.0117	CbGeAlD
Valproic Acid—OGDH—testis—sarcoma	0.00132	0.0115	CbGeAlD
Valproic Acid—ALDH5A1—cardiac atrium—sarcoma	0.00128	0.0111	CbGeAlD
Valproic Acid—ACADSB—tendon—sarcoma	0.00127	0.011	CbGeAlD
Valproic Acid—OGDH—liver—sarcoma	0.00125	0.0109	CbGeAlD
Valproic Acid—ACADSB—bone marrow—sarcoma	0.00123	0.0107	CbGeAlD
Valproic Acid—HDAC2—embryo—sarcoma	0.00122	0.0106	CbGeAlD
Valproic Acid—UGT1A3—liver—sarcoma	0.0012	0.0104	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—sarcoma	0.00119	0.0103	CbGeAlD
Valproic Acid—HDAC9—testis—sarcoma	0.00116	0.0101	CbGeAlD
Valproic Acid—UGT2B15—liver—sarcoma	0.00112	0.00978	CbGeAlD
Valproic Acid—ALDH5A1—tendon—sarcoma	0.00111	0.00969	CbGeAlD
Valproic Acid—HDAC2—hematopoietic system—sarcoma	0.00109	0.00944	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—sarcoma	0.00108	0.00939	CbGeAlD
Valproic Acid—ACADSB—testis—sarcoma	0.00105	0.00912	CbGeAlD
Valproic Acid—HDAC2—connective tissue—sarcoma	0.00105	0.00909	CbGeAlD
Valproic Acid—UGT1A4—liver—sarcoma	0.00102	0.00885	CbGeAlD
Valproic Acid—CYP2A6—seminal vesicle—sarcoma	0.001	0.0087	CbGeAlD
Valproic Acid—ACADSB—liver—sarcoma	0.000991	0.00862	CbGeAlD
Valproic Acid—SLC16A1—hematopoietic system—sarcoma	0.000965	0.00839	CbGeAlD
Valproic Acid—OGDH—lymph node—sarcoma	0.000957	0.00832	CbGeAlD
Valproic Acid—HDAC2—smooth muscle tissue—sarcoma	0.000956	0.00831	CbGeAlD
Valproic Acid—ABAT—tendon—sarcoma	0.000954	0.00829	CbGeAlD
Valproic Acid—HDAC2—skin of body—sarcoma	0.000944	0.00821	CbGeAlD
Valproic Acid—ALDH5A1—testis—sarcoma	0.000923	0.00803	CbGeAlD
Valproic Acid—SLC22A5—mammary gland—sarcoma	0.000905	0.00787	CbGeAlD
Valproic Acid—PTGS1—endothelium—sarcoma	0.000881	0.00766	CbGeAlD
Valproic Acid—CYP2C8—mammary gland—sarcoma	0.000876	0.00762	CbGeAlD
Valproic Acid—ALDH5A1—liver—sarcoma	0.000873	0.00759	CbGeAlD
Valproic Acid—UGT1A9—liver—sarcoma	0.000852	0.00741	CbGeAlD
Valproic Acid—HDAC9—lymph node—sarcoma	0.000843	0.00733	CbGeAlD
Valproic Acid—HDAC2—uterus—sarcoma	0.00082	0.00713	CbGeAlD
Valproic Acid—ABAT—testis—sarcoma	0.00079	0.00687	CbGeAlD
Valproic Acid—CYP2C9—mammary gland—sarcoma	0.000778	0.00676	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—sarcoma	0.000764	0.00665	CbGeAlD
Valproic Acid—ACADSB—lymph node—sarcoma	0.00076	0.00661	CbGeAlD
Valproic Acid—ABAT—liver—sarcoma	0.000747	0.00649	CbGeAlD
Valproic Acid—CYP2C18—liver—sarcoma	0.000745	0.00648	CbGeAlD
Valproic Acid—SLC16A1—cardiac atrium—sarcoma	0.000732	0.00637	CbGeAlD
Valproic Acid—SLC22A8—hematopoietic system—sarcoma	0.000729	0.00634	CbGeAlD
Valproic Acid—SLC16A1—uterus—sarcoma	0.000729	0.00634	CbGeAlD
Valproic Acid—UGT2B7—testis—sarcoma	0.000727	0.00632	CbGeAlD
Valproic Acid—HDAC2—tendon—sarcoma	0.000718	0.00625	CbGeAlD
Valproic Acid—HDAC2—bone marrow—sarcoma	0.000696	0.00605	CbGeAlD
Valproic Acid—SLC22A7—testis—sarcoma	0.000691	0.00601	CbGeAlD
Valproic Acid—UGT2B7—liver—sarcoma	0.000687	0.00598	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—sarcoma	0.000669	0.00582	CbGeAlD
Valproic Acid—SLC22A7—liver—sarcoma	0.000654	0.00568	CbGeAlD
Valproic Acid—SLC22A5—myometrium—sarcoma	0.000642	0.00558	CbGeAlD
Valproic Acid—SLC16A1—tendon—sarcoma	0.000638	0.00555	CbGeAlD
Valproic Acid—CYP2C19—hematopoietic system—sarcoma	0.000611	0.00532	CbGeAlD
Valproic Acid—HDAC2—testis—sarcoma	0.000595	0.00517	CbGeAlD
Valproic Acid—SLC22A5—seminal vesicle—sarcoma	0.00058	0.00504	CbGeAlD
Valproic Acid—ABAT—lymph node—sarcoma	0.000572	0.00498	CbGeAlD
Valproic Acid—HDAC2—liver—sarcoma	0.000562	0.00489	CbGeAlD
Valproic Acid—CYP2C8—hematopoietic system—sarcoma	0.000534	0.00464	CbGeAlD
Valproic Acid—SLC16A1—testis—sarcoma	0.000529	0.0046	CbGeAlD
Valproic Acid—SLC16A1—liver—sarcoma	0.0005	0.00435	CbGeAlD
Valproic Acid—CYP1A2—hematopoietic system—sarcoma	0.000499	0.00434	CbGeAlD
Valproic Acid—CYP2A6—liver—sarcoma	0.000492	0.00428	CbGeAlD
Valproic Acid—CYP3A5—hematopoietic system—sarcoma	0.000482	0.00419	CbGeAlD
Valproic Acid—SLC22A5—skin of body—sarcoma	0.000479	0.00417	CbGeAlD
Valproic Acid—CYP2B6—hematopoietic system—sarcoma	0.000479	0.00416	CbGeAlD
Valproic Acid—CYP2C9—hematopoietic system—sarcoma	0.000474	0.00412	CbGeAlD
Valproic Acid—PTGS1—seminal vesicle—sarcoma	0.000455	0.00396	CbGeAlD
Valproic Acid—PTGS1—hematopoietic system—sarcoma	0.000433	0.00376	CbGeAlD
Valproic Acid—HDAC2—lymph node—sarcoma	0.000431	0.00375	CbGeAlD
Valproic Acid—SLC22A5—cardiac atrium—sarcoma	0.000418	0.00364	CbGeAlD
Valproic Acid—PTGS1—connective tissue—sarcoma	0.000417	0.00362	CbGeAlD
Valproic Acid—CYP2B6—skin of body—sarcoma	0.000416	0.00362	CbGeAlD
Valproic Acid—SLC16A1—lymph node—sarcoma	0.000383	0.00333	CbGeAlD
Valproic Acid—PTGS1—smooth muscle tissue—sarcoma	0.000381	0.00331	CbGeAlD
Valproic Acid—PTGS1—skin of body—sarcoma	0.000376	0.00327	CbGeAlD
Valproic Acid—SLC22A5—tendon—sarcoma	0.000365	0.00317	CbGeAlD
Valproic Acid—CYP3A4—hematopoietic system—sarcoma	0.000361	0.00314	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—sarcoma	0.000337	0.00293	CbGeAlD
Valproic Acid—PTGS1—cardiac atrium—sarcoma	0.000329	0.00286	CbGeAlD
Valproic Acid—PTGS1—uterus—sarcoma	0.000327	0.00284	CbGeAlD
Valproic Acid—CYP2C19—liver—sarcoma	0.000317	0.00275	CbGeAlD
Valproic Acid—SLC22A5—testis—sarcoma	0.000302	0.00263	CbGeAlD
Valproic Acid—CYP2C8—testis—sarcoma	0.000292	0.00254	CbGeAlD
Valproic Acid—PTGS1—tendon—sarcoma	0.000286	0.00249	CbGeAlD
Valproic Acid—SLC22A5—liver—sarcoma	0.000286	0.00248	CbGeAlD
Valproic Acid—CYP2C8—liver—sarcoma	0.000276	0.0024	CbGeAlD
Valproic Acid—CYP2B6—testis—sarcoma	0.000262	0.00228	CbGeAlD
Valproic Acid—CYP1A2—liver—sarcoma	0.000259	0.00225	CbGeAlD
Valproic Acid—CYP3A5—liver—sarcoma	0.000249	0.00217	CbGeAlD
Valproic Acid—CYP2B6—liver—sarcoma	0.000248	0.00216	CbGeAlD
Valproic Acid—CYP2C9—liver—sarcoma	0.000246	0.00214	CbGeAlD
Valproic Acid—PTGS1—testis—sarcoma	0.000237	0.00206	CbGeAlD
Valproic Acid—SLC22A5—lymph node—sarcoma	0.000219	0.0019	CbGeAlD
Valproic Acid—CYP3A4—liver—sarcoma	0.000187	0.00163	CbGeAlD
Valproic Acid—Influenza—Doxorubicin—sarcoma	0.000186	0.00074	CcSEcCtD
Valproic Acid—Dysphagia—Doxorubicin—sarcoma	0.000186	0.00074	CcSEcCtD
Valproic Acid—Pollakiuria—Epirubicin—sarcoma	0.000185	0.000739	CcSEcCtD
Valproic Acid—Hypersensitivity—Vincristine—sarcoma	0.000185	0.000738	CcSEcCtD
Valproic Acid—Eosinophilia—Doxorubicin—sarcoma	0.000184	0.000732	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Epirubicin—sarcoma	0.000183	0.00073	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—sarcoma	0.000183	0.000728	CcSEcCtD
Valproic Acid—Weight increased—Epirubicin—sarcoma	0.000183	0.000728	CcSEcCtD
Valproic Acid—Pancreatitis—Doxorubicin—sarcoma	0.000182	0.000725	CcSEcCtD
Valproic Acid—Weight decreased—Epirubicin—sarcoma	0.000181	0.000723	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—sarcoma	0.000181	0.000723	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—sarcoma	0.000181	0.000721	CcSEcCtD
Valproic Acid—Hypersensitivity—Mitoxantrone—sarcoma	0.00018	0.000718	CcSEcCtD
Valproic Acid—Asthenia—Vincristine—sarcoma	0.00018	0.000718	CcSEcCtD
Valproic Acid—Vomiting—Thiotepa—sarcoma	0.00018	0.000718	CcSEcCtD
Valproic Acid—Pneumonia—Epirubicin—sarcoma	0.00018	0.000717	CcSEcCtD
Valproic Acid—Drowsiness—Epirubicin—sarcoma	0.000179	0.000713	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—sarcoma	0.000179	0.000713	CcSEcCtD
Valproic Acid—Rash—Thiotepa—sarcoma	0.000179	0.000712	CcSEcCtD
Valproic Acid—Bronchitis—Doxorubicin—sarcoma	0.000179	0.000711	CcSEcCtD
Valproic Acid—Dermatitis—Thiotepa—sarcoma	0.000178	0.000711	CcSEcCtD
Valproic Acid—Headache—Thiotepa—sarcoma	0.000177	0.000707	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000177	0.000707	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—sarcoma	0.000177	0.000707	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—sarcoma	0.000177	0.000705	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—sarcoma	0.000176	0.000703	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—sarcoma	0.000176	0.0007	CcSEcCtD
Valproic Acid—Asthenia—Mitoxantrone—sarcoma	0.000176	0.0007	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—sarcoma	0.000175	0.000699	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—sarcoma	0.000174	0.000695	CcSEcCtD
Valproic Acid—Pain—Etoposide—sarcoma	0.000174	0.000694	CcSEcCtD
Valproic Acid—Constipation—Etoposide—sarcoma	0.000174	0.000694	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—sarcoma	0.000174	0.000693	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—sarcoma	0.000174	0.000693	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—sarcoma	0.000174	0.000692	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—sarcoma	0.000174	0.000692	CcSEcCtD
Valproic Acid—Diarrhoea—Vincristine—sarcoma	0.000172	0.000685	CcSEcCtD
Valproic Acid—PTGS1—lymph node—sarcoma	0.000172	0.00149	CbGeAlD
Valproic Acid—Sweating—Epirubicin—sarcoma	0.000171	0.000683	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—sarcoma	0.000171	0.000683	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—sarcoma	0.000169	0.000675	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—sarcoma	0.000169	0.000674	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—sarcoma	0.000169	0.000673	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—sarcoma	0.000169	0.000672	CcSEcCtD
Valproic Acid—Nausea—Thiotepa—sarcoma	0.000168	0.000671	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—sarcoma	0.000168	0.000669	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—sarcoma	0.000168	0.000669	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—sarcoma	0.000168	0.000668	CcSEcCtD
Valproic Acid—Diarrhoea—Mitoxantrone—sarcoma	0.000167	0.000667	CcSEcCtD
Valproic Acid—Nausea—Dactinomycin—sarcoma	0.000167	0.000666	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—sarcoma	0.000167	0.000665	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—sarcoma	0.000166	0.000663	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—sarcoma	0.000166	0.000663	CcSEcCtD
Valproic Acid—Dizziness—Vincristine—sarcoma	0.000166	0.000662	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—sarcoma	0.000166	0.00066	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000164	0.000654	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—sarcoma	0.000163	0.000651	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—sarcoma	0.000162	0.000644	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—sarcoma	0.000161	0.000643	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—sarcoma	0.000161	0.000643	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—sarcoma	0.000161	0.000642	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—sarcoma	0.000161	0.000641	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—sarcoma	0.000161	0.000641	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—sarcoma	0.000161	0.000641	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—sarcoma	0.000161	0.000641	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—sarcoma	0.000161	0.00064	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—sarcoma	0.00016	0.000637	CcSEcCtD
Valproic Acid—Vomiting—Vincristine—sarcoma	0.00016	0.000637	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—sarcoma	0.000159	0.000635	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—sarcoma	0.000159	0.000632	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—sarcoma	0.000159	0.000632	CcSEcCtD
Valproic Acid—Rash—Vincristine—sarcoma	0.000158	0.000631	CcSEcCtD
Valproic Acid—Dermatitis—Vincristine—sarcoma	0.000158	0.000631	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—sarcoma	0.000158	0.00063	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—sarcoma	0.000158	0.000629	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—sarcoma	0.000157	0.000627	CcSEcCtD
Valproic Acid—Headache—Vincristine—sarcoma	0.000157	0.000627	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—sarcoma	0.000157	0.000624	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—sarcoma	0.000156	0.000622	CcSEcCtD
Valproic Acid—Vomiting—Mitoxantrone—sarcoma	0.000156	0.00062	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—sarcoma	0.000155	0.000619	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—sarcoma	0.000155	0.000617	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—sarcoma	0.000154	0.000616	CcSEcCtD
Valproic Acid—Rash—Mitoxantrone—sarcoma	0.000154	0.000615	CcSEcCtD
Valproic Acid—Dermatitis—Mitoxantrone—sarcoma	0.000154	0.000614	CcSEcCtD
Valproic Acid—Headache—Mitoxantrone—sarcoma	0.000153	0.000611	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—sarcoma	0.000152	0.000605	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—sarcoma	0.000151	0.000603	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—sarcoma	0.00015	0.000598	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—sarcoma	0.00015	0.000598	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—sarcoma	0.00015	0.000597	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—sarcoma	0.000149	0.000595	CcSEcCtD
Valproic Acid—Nausea—Vincristine—sarcoma	0.000149	0.000595	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—sarcoma	0.000149	0.000594	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—sarcoma	0.000149	0.000592	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—sarcoma	0.000148	0.000589	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—CCND1—sarcoma	0.000148	0.00299	CbGpPWpGaD
Valproic Acid—Pharyngitis—Doxorubicin—sarcoma	0.000147	0.000588	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—JUN—sarcoma	0.000147	0.00298	CbGpPWpGaD
Valproic Acid—Urinary tract disorder—Doxorubicin—sarcoma	0.000147	0.000585	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—sarcoma	0.000146	0.000583	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—sarcoma	0.000146	0.000582	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—sarcoma	0.000146	0.000582	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.000146	0.00295	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000146	0.00295	CbGpPWpGaD
Valproic Acid—Angiopathy—Epirubicin—sarcoma	0.000146	0.000581	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—sarcoma	0.000146	0.00058	CcSEcCtD
Valproic Acid—Nausea—Mitoxantrone—sarcoma	0.000145	0.000579	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—sarcoma	0.000145	0.000578	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—sarcoma	0.000145	0.000577	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—CREB1—sarcoma	0.000144	0.00292	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—SRC—sarcoma	0.000144	0.00292	CbGpPWpGaD
Valproic Acid—Chills—Epirubicin—sarcoma	0.000144	0.000574	CcSEcCtD
Valproic Acid—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000144	0.00292	CbGpPWpGaD
Valproic Acid—Pruritus—Etoposide—sarcoma	0.000144	0.000574	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—sarcoma	0.000143	0.000572	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—sarcoma	0.000143	0.000571	CcSEcCtD
Valproic Acid—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.000143	0.00289	CbGpPWpGaD
Valproic Acid—Alopecia—Epirubicin—sarcoma	0.000142	0.000566	CcSEcCtD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000142	0.00287	CbGpPWpGaD
Valproic Acid—Mental disorder—Epirubicin—sarcoma	0.000141	0.000561	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—sarcoma	0.00014	0.00056	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—CREB1—sarcoma	0.00014	0.00284	CbGpPWpGaD
Valproic Acid—Malnutrition—Epirubicin—sarcoma	0.00014	0.000557	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—sarcoma	0.000139	0.000555	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—sarcoma	0.000139	0.000553	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—sarcoma	0.000139	0.000552	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—TEK—sarcoma	0.000138	0.0028	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—ANGPT2—sarcoma	0.000138	0.0028	CbGpPWpGaD
Valproic Acid—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—sarcoma	0.000138	0.0028	CbGpPWpGaD
Valproic Acid—Flatulence—Epirubicin—sarcoma	0.000138	0.000549	CcSEcCtD
Valproic Acid—Tension—Epirubicin—sarcoma	0.000137	0.000547	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—sarcoma	0.000137	0.000546	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—sarcoma	0.000136	0.000541	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—sarcoma	0.000135	0.000539	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—sarcoma	0.000135	0.000537	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—sarcoma	0.000135	0.000536	CcSEcCtD
Valproic Acid—OGDH—Metabolism—ENO2—sarcoma	0.000135	0.00272	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TLE1—sarcoma	0.000135	0.00272	CbGpPWpGaD
Valproic Acid—Muscle spasms—Epirubicin—sarcoma	0.000134	0.000536	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—PLCG1—sarcoma	0.000134	0.00272	CbGpPWpGaD
Valproic Acid—Immune system disorder—Doxorubicin—sarcoma	0.000134	0.000535	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—sarcoma	0.000134	0.000534	CcSEcCtD
Valproic Acid—OGDH—Metabolism—HBA1—sarcoma	0.000134	0.00271	CbGpPWpGaD
Valproic Acid—Chills—Doxorubicin—sarcoma	0.000133	0.000531	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—sarcoma	0.000133	0.000529	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—sarcoma	0.000132	0.000525	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—sarcoma	0.000131	0.000523	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.00013	0.00264	CbGpPWpGaD
Valproic Acid—Mental disorder—Doxorubicin—sarcoma	0.00013	0.000519	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—sarcoma	0.00013	0.000517	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	0.00013	0.00262	CbGpPWpGaD
Valproic Acid—Vomiting—Etoposide—sarcoma	0.000129	0.000516	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—sarcoma	0.000129	0.000515	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	0.000129	0.00262	CbGpPWpGaD
Valproic Acid—Anaemia—Epirubicin—sarcoma	0.000129	0.000515	CcSEcCtD
Valproic Acid—HDAC2—Notch Signaling Pathway—MYC—sarcoma	0.000129	0.00261	CbGpPWpGaD
Valproic Acid—Agitation—Epirubicin—sarcoma	0.000128	0.000512	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	0.000128	0.0026	CbGpPWpGaD
Valproic Acid—Rash—Etoposide—sarcoma	0.000128	0.000511	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—sarcoma	0.000128	0.000511	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000128	0.00259	CbGpPWpGaD
Valproic Acid—Headache—Etoposide—sarcoma	0.000127	0.000508	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—sarcoma	0.000127	0.000508	CcSEcCtD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000127	0.00257	CbGpPWpGaD
Valproic Acid—Tension—Doxorubicin—sarcoma	0.000127	0.000506	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.000127	0.00257	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ANGPT2—sarcoma	0.000127	0.00256	CbGpPWpGaD
Valproic Acid—Dysgeusia—Doxorubicin—sarcoma	0.000127	0.000505	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—PLCG1—sarcoma	0.000126	0.00255	CbGpPWpGaD
Valproic Acid—Malaise—Epirubicin—sarcoma	0.000126	0.000502	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—sarcoma	0.000126	0.000501	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—sarcoma	0.000126	0.000501	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—sarcoma	0.000125	0.000499	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—sarcoma	0.000125	0.000499	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—sarcoma	0.000124	0.000496	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—sarcoma	0.000124	0.000492	CcSEcCtD
Valproic Acid—HDAC2—Cell Cycle—MDM2—sarcoma	0.000122	0.00248	CbGpPWpGaD
Valproic Acid—Cough—Epirubicin—sarcoma	0.000122	0.000486	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—sarcoma	0.000122	0.000486	CcSEcCtD
Valproic Acid—HDAC9—Disease—NPM1—sarcoma	0.000121	0.00246	CbGpPWpGaD
Valproic Acid—Nausea—Etoposide—sarcoma	0.000121	0.000482	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—sarcoma	0.000121	0.000481	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—sarcoma	0.00012	0.000478	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—ATF1—sarcoma	0.00012	0.00242	CbGpPWpGaD
Valproic Acid—Anaemia—Doxorubicin—sarcoma	0.00012	0.000476	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—MDM2—sarcoma	0.000119	0.00241	CbGpPWpGaD
Valproic Acid—Arthralgia—Epirubicin—sarcoma	0.000119	0.000474	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—sarcoma	0.000119	0.000474	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—sarcoma	0.000119	0.000474	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—sarcoma	0.000119	0.000474	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—sarcoma	0.000119	0.000473	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—MYC—sarcoma	0.000118	0.0024	CbGpPWpGaD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000118	0.000471	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—sarcoma	0.000118	0.000469	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—sarcoma	0.000117	0.000465	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—sarcoma	0.000116	0.000464	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—sarcoma	0.000116	0.000463	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—EGFR—sarcoma	0.000116	0.00234	CbGpPWpGaD
Valproic Acid—Leukopenia—Doxorubicin—sarcoma	0.000116	0.000461	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—sarcoma	0.000115	0.000458	CcSEcCtD
Valproic Acid—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—sarcoma	0.000114	0.00231	CbGpPWpGaD
Valproic Acid—Palpitations—Doxorubicin—sarcoma	0.000114	0.000456	CcSEcCtD
Valproic Acid—OGDH—Metabolism—PLCG1—sarcoma	0.000114	0.00231	CbGpPWpGaD
Valproic Acid—Anaphylactic shock—Epirubicin—sarcoma	0.000114	0.000455	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—sarcoma	0.000114	0.000455	CcSEcCtD
Valproic Acid—Infection—Epirubicin—sarcoma	0.000113	0.000452	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—sarcoma	0.000113	0.00045	CcSEcCtD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000113	0.00228	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Epirubicin—sarcoma	0.000112	0.000446	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—sarcoma	0.000112	0.000445	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—sarcoma	0.000112	0.000445	CcSEcCtD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000112	0.00226	CbGpPWpGaD
Valproic Acid—Tachycardia—Epirubicin—sarcoma	0.000111	0.000444	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—VEGFC—sarcoma	0.000111	0.00225	CbGpPWpGaD
Valproic Acid—Skin disorder—Epirubicin—sarcoma	0.000111	0.000442	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—sarcoma	0.00011	0.00044	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—sarcoma	0.00011	0.000439	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—sarcoma	0.00011	0.000439	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—sarcoma	0.00011	0.000439	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—sarcoma	0.00011	0.000437	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000109	0.000436	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—sarcoma	0.000109	0.000434	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—sarcoma	0.000109	0.000433	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—sarcoma	0.000108	0.000429	CcSEcCtD
Valproic Acid—HDAC2—Direct p53 effectors—MMP2—sarcoma	0.000107	0.00216	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—SRC—sarcoma	0.000107	0.00216	CbGpPWpGaD
Valproic Acid—Hypotension—Epirubicin—sarcoma	0.000107	0.000425	CcSEcCtD
Valproic Acid—HDAC2—Neural Crest Differentiation—CTNNB1—sarcoma	0.000106	0.00216	CbGpPWpGaD
Valproic Acid—Confusional state—Doxorubicin—sarcoma	0.000106	0.000424	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—sarcoma	0.000106	0.000421	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—sarcoma	0.000106	0.000421	CcSEcCtD
Valproic Acid—HDAC9—Disease—ENO2—sarcoma	0.000105	0.00213	CbGpPWpGaD
Valproic Acid—Infection—Doxorubicin—sarcoma	0.000105	0.000418	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000104	0.0021	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000104	0.000414	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—sarcoma	0.000104	0.000413	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—sarcoma	0.000103	0.000412	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—sarcoma	0.000103	0.000411	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—sarcoma	0.000103	0.000411	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000103	0.00208	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—sarcoma	0.000103	0.00208	CbGpPWpGaD
Valproic Acid—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000103	0.00208	CbGpPWpGaD
Valproic Acid—Skin disorder—Doxorubicin—sarcoma	0.000103	0.000409	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—sarcoma	0.000102	0.000408	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—sarcoma	0.000102	0.000407	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—sarcoma	0.000102	0.000405	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—VEGFC—sarcoma	0.000102	0.00206	CbGpPWpGaD
Valproic Acid—Somnolence—Epirubicin—sarcoma	0.000101	0.000404	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—CCND1—sarcoma	0.000101	0.00205	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—JUN—sarcoma	0.000101	0.00204	CbGpPWpGaD
Valproic Acid—Anorexia—Doxorubicin—sarcoma	0.000101	0.000401	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—sarcoma	0.0001	0.0004	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—sarcoma	9.92e-05	0.000395	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—sarcoma	9.86e-05	0.000393	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—sarcoma	9.85e-05	0.000393	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—sarcoma	9.84e-05	0.000392	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—sarcoma	9.76e-05	0.000389	CcSEcCtD
Valproic Acid—Pain—Epirubicin—sarcoma	9.76e-05	0.000389	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.62e-05	0.000383	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—sarcoma	9.55e-05	0.00038	CcSEcCtD
Valproic Acid—HDAC2—Gene Expression—FUS—sarcoma	9.53e-05	0.00193	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—MDM2—sarcoma	9.51e-05	0.00192	CbGpPWpGaD
Valproic Acid—Paraesthesia—Doxorubicin—sarcoma	9.48e-05	0.000378	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—TLE1—sarcoma	9.42e-05	0.00191	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	9.41e-05	0.00191	CbGpPWpGaD
Valproic Acid—Dyspnoea—Doxorubicin—sarcoma	9.41e-05	0.000375	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—sarcoma	9.4e-05	0.000375	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—sarcoma	9.38e-05	0.000374	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—sarcoma	9.33e-05	0.000372	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—sarcoma	9.29e-05	0.00037	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—sarcoma	9.18e-05	0.000366	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—sarcoma	9.11e-05	0.000363	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—sarcoma	9.1e-05	0.000363	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—sarcoma	9.06e-05	0.000361	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—sarcoma	9.03e-05	0.00036	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—sarcoma	9.03e-05	0.00036	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—sarcoma	9.02e-05	0.000359	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—sarcoma	9.02e-05	0.000359	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—FOXO1—sarcoma	8.95e-05	0.00181	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—PDGFRB—sarcoma	8.93e-05	0.00181	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PLCG1—sarcoma	8.92e-05	0.0018	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—sarcoma	8.85e-05	0.00179	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—PDGFRA—sarcoma	8.79e-05	0.00178	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PLCG1—sarcoma	8.73e-05	0.00177	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Doxorubicin—sarcoma	8.7e-05	0.000347	CcSEcCtD
Valproic Acid—ALDH5A1—Neuronal System—HRAS—sarcoma	8.64e-05	0.00175	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Doxorubicin—sarcoma	8.63e-05	0.000344	CcSEcCtD
Valproic Acid—HDAC2—Neural Crest Differentiation—MYC—sarcoma	8.63e-05	0.00175	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CREB1—sarcoma	8.6e-05	0.00174	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CXCR4—sarcoma	8.57e-05	0.00173	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—HRAS—sarcoma	8.54e-05	0.00173	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Epirubicin—sarcoma	8.4e-05	0.000335	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—sarcoma	8.39e-05	0.000334	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—sarcoma	8.37e-05	0.00169	CbGpPWpGaD
Valproic Acid—Abdominal pain—Doxorubicin—sarcoma	8.34e-05	0.000333	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—sarcoma	8.34e-05	0.000333	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—ENO2—sarcoma	8.31e-05	0.00168	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—JUN—sarcoma	8.26e-05	0.00167	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—HBA1—sarcoma	8.26e-05	0.00167	CbGpPWpGaD
Valproic Acid—Asthenia—Epirubicin—sarcoma	8.18e-05	0.000326	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—MYC—sarcoma	8.12e-05	0.00164	CbGpPWpGaD
Valproic Acid—Pruritus—Epirubicin—sarcoma	8.07e-05	0.000322	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—PLCG1—sarcoma	7.99e-05	0.00162	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFC—sarcoma	7.95e-05	0.00161	CbGpPWpGaD
Valproic Acid—Diarrhoea—Epirubicin—sarcoma	7.81e-05	0.000311	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—sarcoma	7.78e-05	0.00031	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—sarcoma	7.57e-05	0.000302	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—sarcoma	7.54e-05	0.000301	CcSEcCtD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—sarcoma	7.53e-05	0.00152	CbGpPWpGaD
Valproic Acid—Pruritus—Doxorubicin—sarcoma	7.47e-05	0.000298	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—ENO2—sarcoma	7.27e-05	0.00147	CbGpPWpGaD
Valproic Acid—Vomiting—Epirubicin—sarcoma	7.25e-05	0.000289	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—sarcoma	7.22e-05	0.000288	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—HBA1—sarcoma	7.22e-05	0.00146	CbGpPWpGaD
Valproic Acid—Rash—Epirubicin—sarcoma	7.19e-05	0.000287	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—sarcoma	7.19e-05	0.000286	CcSEcCtD
Valproic Acid—Headache—Epirubicin—sarcoma	7.15e-05	0.000285	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—PLCG1—sarcoma	7.05e-05	0.00143	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—sarcoma	7.03e-05	0.00142	CbGpPWpGaD
Valproic Acid—Dizziness—Doxorubicin—sarcoma	6.98e-05	0.000278	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—KIT—sarcoma	6.82e-05	0.00138	CbGpPWpGaD
Valproic Acid—Nausea—Epirubicin—sarcoma	6.78e-05	0.00027	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—sarcoma	6.71e-05	0.000267	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—sarcoma	6.66e-05	0.00135	CbGpPWpGaD
Valproic Acid—Rash—Doxorubicin—sarcoma	6.66e-05	0.000265	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—sarcoma	6.65e-05	0.000265	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—sarcoma	6.61e-05	0.000264	CcSEcCtD
Valproic Acid—ABAT—Neuronal System—HRAS—sarcoma	6.54e-05	0.00132	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—sarcoma	6.5e-05	0.00131	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—CREB1—sarcoma	6.49e-05	0.00131	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FLT1—sarcoma	6.35e-05	0.00129	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—FOXO1—sarcoma	6.33e-05	0.00128	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PDGFRB—sarcoma	6.32e-05	0.00128	CbGpPWpGaD
Valproic Acid—Nausea—Doxorubicin—sarcoma	6.27e-05	0.00025	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—PLCG1—sarcoma	6.25e-05	0.00126	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PDGFRA—sarcoma	6.22e-05	0.00126	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—JUN—sarcoma	6.19e-05	0.00125	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PLCG1—sarcoma	6.17e-05	0.00125	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ENO2—sarcoma	6.06e-05	0.00123	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—HBA1—sarcoma	6.03e-05	0.00122	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCR4—sarcoma	6e-05	0.00121	CbGpPWpGaD
Valproic Acid—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	5.98e-05	0.00121	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ATF1—sarcoma	5.93e-05	0.0012	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TLE1—sarcoma	5.83e-05	0.00118	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CCND1—sarcoma	5.83e-05	0.00118	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—sarcoma	5.58e-05	0.00113	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—sarcoma	5.46e-05	0.0011	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MDM2—sarcoma	5.37e-05	0.00109	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	5.34e-05	0.00108	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NPM1—sarcoma	5.26e-05	0.00106	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	5.19e-05	0.00105	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PLCG1—sarcoma	5.15e-05	0.00104	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KIT—sarcoma	4.82e-05	0.000976	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—sarcoma	4.68e-05	0.000948	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.66e-05	0.000943	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.66e-05	0.000943	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IGF1R—sarcoma	4.66e-05	0.000942	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—HBA1—sarcoma	4.65e-05	0.000942	CbGpPWpGaD
Valproic Acid—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.61e-05	0.000933	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CREB1—sarcoma	4.59e-05	0.000929	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—sarcoma	4.56e-05	0.000922	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.54e-05	0.000918	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.48e-05	0.000907	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FOXO1—sarcoma	4.43e-05	0.000897	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PDGFRB—sarcoma	4.42e-05	0.000895	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PDGFRA—sarcoma	4.35e-05	0.000881	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—SRC—sarcoma	4.19e-05	0.000847	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.18e-05	0.000845	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ENO2—sarcoma	4.17e-05	0.000845	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—HBA1—sarcoma	4.15e-05	0.000839	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TLE1—sarcoma	4.08e-05	0.000827	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—sarcoma	4.08e-05	0.000827	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.08e-05	0.000826	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	4.08e-05	0.000826	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NRAS—sarcoma	4.03e-05	0.000815	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PLCG1—sarcoma	3.97e-05	0.000804	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ENO2—sarcoma	3.89e-05	0.000788	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—HBA1—sarcoma	3.87e-05	0.000783	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PLCG1—sarcoma	3.87e-05	0.000783	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.86e-05	0.000781	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MDM2—sarcoma	3.8e-05	0.000769	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CXCR4—sarcoma	3.72e-05	0.000752	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—sarcoma	3.67e-05	0.000743	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KDR—sarcoma	3.67e-05	0.000742	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PLCG1—sarcoma	3.54e-05	0.000717	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—KRAS—sarcoma	3.47e-05	0.000701	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFC—sarcoma	3.45e-05	0.000697	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—sarcoma	3.4e-05	0.000689	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—HBA1—sarcoma	3.38e-05	0.000684	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIT—sarcoma	3.38e-05	0.000683	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL2—sarcoma	3.32e-05	0.000672	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—sarcoma	3.31e-05	0.00067	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PLCG1—sarcoma	3.3e-05	0.000668	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—HBA1—sarcoma	3.29e-05	0.000666	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.28e-05	0.000664	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CTNNB1—sarcoma	3.28e-05	0.000663	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CREB1—sarcoma	3.21e-05	0.00065	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL2—sarcoma	3.04e-05	0.000615	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SRC—sarcoma	2.96e-05	0.000599	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—sarcoma	2.95e-05	0.000596	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—SRC—sarcoma	2.9e-05	0.000587	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PLCG1—sarcoma	2.89e-05	0.000584	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—sarcoma	2.85e-05	0.000576	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—sarcoma	2.82e-05	0.000572	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PLCG1—sarcoma	2.81e-05	0.000568	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—sarcoma	2.79e-05	0.000565	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FLT1—sarcoma	2.76e-05	0.000558	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FOXO1—sarcoma	2.74e-05	0.000555	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PDGFRB—sarcoma	2.74e-05	0.000554	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PLCG1—sarcoma	2.71e-05	0.000548	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PDGFRA—sarcoma	2.7e-05	0.000546	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—sarcoma	2.69e-05	0.000544	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—HBA1—sarcoma	2.67e-05	0.000541	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MDM2—sarcoma	2.66e-05	0.000538	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—sarcoma	2.65e-05	0.000537	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—SRC—sarcoma	2.65e-05	0.000537	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCR4—sarcoma	2.6e-05	0.000527	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—sarcoma	2.6e-05	0.000525	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—sarcoma	2.58e-05	0.000523	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ATF1—sarcoma	2.57e-05	0.000521	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—sarcoma	2.55e-05	0.000516	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KRAS—sarcoma	2.45e-05	0.000496	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—sarcoma	2.4e-05	0.000486	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2—sarcoma	2.38e-05	0.000481	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—sarcoma	2.32e-05	0.000469	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—JUN—sarcoma	2.31e-05	0.000468	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CTNNB1—sarcoma	2.29e-05	0.000464	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PLCG1—sarcoma	2.28e-05	0.000462	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—sarcoma	2.2e-05	0.000444	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—sarcoma	2.19e-05	0.000444	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—HBA1—sarcoma	2.18e-05	0.000441	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—sarcoma	2.13e-05	0.000432	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KIT—sarcoma	2.09e-05	0.000423	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—sarcoma	2.08e-05	0.000422	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SRC—sarcoma	2.07e-05	0.00042	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—sarcoma	2.07e-05	0.00042	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—HBA1—sarcoma	2.06e-05	0.000417	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—sarcoma	2.04e-05	0.000413	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—sarcoma	2.02e-05	0.000409	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF1R—sarcoma	2.02e-05	0.000409	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—sarcoma	1.99e-05	0.000404	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CREB1—sarcoma	1.99e-05	0.000403	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—sarcoma	1.95e-05	0.000395	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FOXO1—sarcoma	1.92e-05	0.000389	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PDGFRB—sarcoma	1.92e-05	0.000388	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PDGFRA—sarcoma	1.89e-05	0.000382	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—sarcoma	1.87e-05	0.000378	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PLCG1—sarcoma	1.86e-05	0.000376	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—sarcoma	1.86e-05	0.000376	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—sarcoma	1.82e-05	0.000368	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PLCG1—sarcoma	1.76e-05	0.000356	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—sarcoma	1.72e-05	0.000347	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—sarcoma	1.67e-05	0.000339	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—HBA1—sarcoma	1.66e-05	0.000336	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MDM2—sarcoma	1.65e-05	0.000333	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—sarcoma	1.63e-05	0.000331	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HBA1—sarcoma	1.62e-05	0.000329	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KDR—sarcoma	1.59e-05	0.000322	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—sarcoma	1.53e-05	0.000309	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIT—sarcoma	1.46e-05	0.000296	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—sarcoma	1.46e-05	0.000295	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—sarcoma	1.42e-05	0.000287	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PLCG1—sarcoma	1.42e-05	0.000287	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—sarcoma	1.42e-05	0.000287	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HBA1—sarcoma	1.41e-05	0.000285	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CREB1—sarcoma	1.39e-05	0.000282	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PLCG1—sarcoma	1.39e-05	0.000281	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SRC—sarcoma	1.28e-05	0.00026	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—sarcoma	1.26e-05	0.000256	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HBA1—sarcoma	1.26e-05	0.000254	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—sarcoma	1.24e-05	0.000251	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—sarcoma	1.24e-05	0.00025	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PLCG1—sarcoma	1.2e-05	0.000243	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—sarcoma	1.15e-05	0.000233	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—sarcoma	1.15e-05	0.000233	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—sarcoma	1.15e-05	0.000233	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HBA1—sarcoma	1.15e-05	0.000232	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—sarcoma	1.13e-05	0.000228	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PLCG1—sarcoma	1.07e-05	0.000217	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—sarcoma	1.06e-05	0.000215	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—sarcoma	1.03e-05	0.000209	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—sarcoma	1e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JUN—sarcoma	1e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—sarcoma	9.95e-06	0.000201	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—sarcoma	9.85e-06	0.000199	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HBA1—sarcoma	9.79e-06	0.000198	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PLCG1—sarcoma	9.78e-06	0.000198	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—sarcoma	9.04e-06	0.000183	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—sarcoma	8.99e-06	0.000182	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—sarcoma	8.76e-06	0.000177	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—sarcoma	8.65e-06	0.000175	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PLCG1—sarcoma	8.36e-06	0.000169	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—sarcoma	8.06e-06	0.000163	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—sarcoma	7.88e-06	0.000159	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—sarcoma	7.6e-06	0.000154	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HBA1—sarcoma	7.55e-06	0.000153	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—sarcoma	7.44e-06	0.000151	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—sarcoma	6.62e-06	0.000134	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLCG1—sarcoma	6.45e-06	0.000131	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—sarcoma	6.33e-06	0.000128	CbGpPWpGaD
